Virtual reality to reduce anxiety during endometriosis-focused transvaginal sonography
RCT
OA: closed
CC0
AI-generated summary
This paper investigates the use of virtual reality to reduce anxiety during endometriosis-focused transvaginal sonography.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To evaluate whether an immersive three-dimensional virtual reality (VR) environment reduces patient anxiety during endometriosis-focused transvaginal sonography (eTVS). Secondary outcomes included pain intensity, physiologic parameters, and patient acceptability.
METHODS: This randomized controlled trial, conducted at a tertiary referral center between December 2023 and August 2024, allocated women undergoing eTVS to VR distraction (VR-eTVS) or standard examination (Control). No a priori sample-size or power calculation was performed. Before and after the examination, participants completed the State-Trait Anxiety Inventory - State Anxiety Scale (STAI-S) and Visual Analog Scale (VAS) for pain. Heart rate (HR) and mean arterial pressure (MAP) were also recorded. Women allocated for VR-eTVS reported their satisfaction and willingness to use the system again.
RESULTS: Of 155 women randomized (80 VR-eTVS; 75 control), four discontinued VR intervention. Baseline anxiety levels were comparable between groups. In the VR group, anxiety decreased significantly after examination [median STAI-S 45 (33-53) vs. 33 (26-44); P < 0.0001], accompanied by a reduction in HR [85 (78-97) vs. 79 (74-89); P = 0.003], while pain remained stable. In the control group, pain increased significantly [3 (0-6) vs. 5 (2-7); P = 0.01], with no significant change in anxiety. Post-procedural anxiety was significantly lower in the VR group compared with controls (P = 0.0001). In an intention-to-treat analysis of all 80 allocated VR participants, 86.3 % reported satisfaction with VR use, and 83.8 % indicated a willingness to use it again.
CONCLUSION: Immersive VR during eTVS was associated with reduced anxiety and stable pain scores. These findings warrant further evaluation in an adequately powered randomized trial.
My notes (saved in your browser only)
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (24)
- Addendum to consensus opinion from International Deep Endometriosis Analysis (IDEA) group: sonographic evaluation of the parametrium via openalex
- Depression, Anxiety, and Self-Directed Violence in Women With Endometriosis: A Retrospective Matched-Cohort Study via openalex
- Endometriosis: A Review via openalex
- EP24.37: Virtual reality for alleviating pain and anxiety during transvaginal sonography for endometriosis: a prospective randomised controlled study via openalex
- Preoperative work-up for patients with deeply infiltrating endometriosis: transvaginal ultrasonography must definitely be the first-line imaging examination via openalex
- Society of Radiologists in Ultrasound Consensus on Routine Pelvic US for Endometriosis via openalex
- Systematic approach to sonographic evaluation of the pelvis in women with suspected endometriosis, including terms, definitions and measurements: a consensus opinion from the International Deep Endometriosis Analysis (IDEA) group via openalex
- "Tenderness-guided" transvaginal ultrasonography: a new method for the detection of deep endometriosis in patients with chronic pelvic pain via openalex
- The unbearable burden of endometriosis: Results from a large cohort about anxiety reduction during the first outpatient evaluation via openalex
- W4386247010 via openalex
- W4387307869 via openalex
- W4388571657 via openalex
- W4390611825 via openalex
- W4391818233 via openalex
- W4410246910 via openalex
- W4412131438 via openalex
- W2102407537 via openalex
- W2792172828 via openalex
- W2810127666 via openalex
- W3096861285 via openalex
- W3134885188 via openalex
- W3159820004 via openalex
- W4367835831 via openalex
- W4378228175 via openalex
Source provenance
- europepmc
- last seen: 2026-11-20T06:18:20.042577+00:00
- openalex
- last seen: 2026-11-12T06:04:30.297530+00:00
- pubmed
- last seen: 2026-11-20T06:11:28.355738+00:00
License: CC0
· commercial use OK